4 April 2022

Clinical COVID-19 Drugs

The upside to sulfasalazine’s covid risk

18 March 2022

Clinical Drugs Medicolegal Political Public Health TGA

Drug approvals ‘rushed, based on limited data’

17 March 2022

Cardio Clinical Drugs

Growing threat of cardiomyopathy in ice users

4 March 2022

COVID-19 Drugs TGA

Access concerns for ‘game-changing’ covid therapy  

2 March 2022

COVID-19 Drugs

Antipyretics ‘reduce covid immunity, help fight TB’

17 February 2022

Clinical Drugs TGA

Drug for nasal polyps gets TGA green light

14 February 2022

Drugs Rheumatology

In knee OA, opioid benefits aren’t worth the cost

10 February 2022

Drugs PBS Political

Naloxone trial ‘saves three Australians a day’

18 January 2022

Clinical Drugs TGA

Reporting medicinal cannabis adverse events to the TGA

16 December 2021

Clinical Drugs

Therapy for meth abuse exists, so why don’t we use it?

16 December 2021

Drugs TGA TheHill

TGA rejects psychedelics down-scheduling

16 December 2021

Drugs Medicolegal

CBD: legal but unavailable

13 December 2021

Clinical Drugs Mental Health

Medicinal cannabis for mental illness

2 December 2021

Clinical Drugs Exercise Rheumatology

Exercise creates ‘cannabis’ that alters gut microbiome

26 November 2021

Clinical Drugs Mental Health Psychology

Psychedelics to treat mental health disorders

22 November 2021

Addiction Clinical Drugs

Poppy seed tea leaves man with opioid addiction